Your browser doesn't support javascript.
loading
Nilotinib cause moyamoya disease in the treatment of chronic myelogenous leukemia during chronic phase: A case report.
Liang, Jin-Ping; Mi, Rui-Hua; Chen, Lin; Wei, Xu-Dong.
Afiliação
  • Liang JP; Department of Hematology, The Affiliated Tumor Hospital of Zhengzhou University, Henan Provincial Cancer Hospital, Zhengzhou, China.
  • Mi RH; Department of Hematology, The Affiliated Tumor Hospital of Zhengzhou University, Henan Provincial Cancer Hospital, Zhengzhou, China.
  • Chen L; Department of Hematology, The Affiliated Tumor Hospital of Zhengzhou University, Henan Provincial Cancer Hospital, Zhengzhou, China.
  • Wei XD; Department of Hematology, The Affiliated Tumor Hospital of Zhengzhou University, Henan Provincial Cancer Hospital, Zhengzhou, China. Electronic address: weixudong63@126.com.
Asian J Surg ; 46(9): 4001-4002, 2023 09.
Article em En | MEDLINE | ID: mdl-37137777
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Doença de Moyamoya / Antineoplásicos Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Doença de Moyamoya / Antineoplásicos Idioma: En Ano de publicação: 2023 Tipo de documento: Article